Cite Filings / ALDX / 0000950170-25-108920

Feed Companies Filings Check

Sign in

SCHEDULE 13G/A

Statement of Beneficial Ownership

Aldeyra Therapeutics, Inc. Filed 2025-08-14 Acc 0000950170-25-108920

Documents 1

SCHEDULE 13G/A Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

2025-11-14 SCHEDULE 13G/A Statement of Beneficial Ownership
2025-08-19 8-K Exhibits
2025-08-15 4 Principal Financial Officer bought 2,500 shares at $5.30 ($13,250)
2025-08-14 SCHEDULE 13G/A Statement of Beneficial Ownership
2025-08-13 4 Chief Development Officer sold 22,073 shares at $5.15 ($113,713)
2025-08-12 144 Sale of Securities
2025-04-07 SCHEDULE 13G/A Statement of Beneficial Ownership

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13G_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…